News

AddToAny

Google+ Facebook Twitter Twitter

HPV primary screening

Following a review of its delivery strategy, NHS England has agreed to begin a one-stage procurement process to reconfigure provider laboratories to support the roll-out of Human Papilloma Virus (HPV) primary screening into the NHS Cervical Cancer Screening Programme in England.

my ibms Microscopic of koilocyte cell criteria of hpv human papilloma virus infection pap smear shutterstock

In coming to this decision, NHS England has taken advice and support from the IBMS, the Royal College of Pathologists and the British Association for Cytopathology.

This decision, based upon learning from market engagement events held earlier this year, will see the procurement commence in November 2018.

To ensure the NHS Cervical Screening Programme continues to deliver a quality service to women during this period of change, NHS England will work with NHS Improvement to give all laboratories that meet the quality criteria the opportunity to implement HPV primary screening ahead of the start of the procurement process.

 

Image Credit | Shutterstock

Related Articles

May journal-based learning exercises

Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

p30-35-cancer-_dr-jhartwell-and-sr.-levy-kornberg_national-cancer-institute_edit-4colbw.jpg

War on cancer pt.2: landmarks in the development of chemotherapy

The second article of two, which briefly reviews the historical developments and use of chemotherapy since 1948 to treat different cancers. 
 

April: News in numbers

A breakdown of science news this month, in numbers.

Liquid biopsy for non-small cell lung cancer

A US multi-centre study revealed that a liquid biopsy is comparable to standard tissue biopsies in detection of guideline recommended biomarkers in advanced non-small cell lung cancer (NSCLC).

Top